UW News

May 6, 2014

Health sciences digest: Drug pricing uproar, antioxidant dangers

UW Medicine Newsroom

The latest news from the UW Health Sciences and UW Medicine:


What price for a cure? The economics of drug pricing

The uproar against the $1,000-a-pill hepatitis C drug Sovaldi, generic name sofosbuvir, may signal a turning point in drug pricing in the United States.  Purchasers appear to be pushing back and saying, “No.”  In a Q & A in HSNewsbeat, Sean Sullivan, professor of pharmacy and health services, explains how drug prices are set and changing attitudes on what purchasers are willing to pay.  Read what he has to say:



Selenium, Vitamin E heighten prostate cancer risk

Some men who take high doses of selenium and vitamin E supplements could increase their risk of aggressive prostate cancer, according to a recent study led by Alan Kristal, professor of epidemiology. Learn more about the potential downside of  taking these antioxidants: